The MarketWatch News Department was not involved in the creation of this content. WeInfuse expands its revenue cycle capabilities and practice management system by integrating with VETRIQ to automate ...

TerSera Therapeutics LLC today announced that it has completed the previously announced sale of its Infusion Specialty Therapies Business Unit (IST), including two specialty medications, Prialt(R) ...

The Infusion Pump Market represents a critical segment within modern healthcare technology, enabling controlled and accurate ...

Frailty can typically only be lessened through lifestyle changes, but a stem cell therapy seems to target the underlying ...

Fresenius has issued a software release to address issues that could interrupt treatment with its Ivenix large volume pumps.

New York City Health + Hospitals/South Brooklyn Health unveiled a $2 million expansion of its Oncology and Infusion Center, ...

Founded by a former Osmosis Lounge owner, Root & Remedy Wellness offers IV therapy, injectables, halotherapy, infrared sauna therapy, and functional medicine.

In participants with highly active disease, the unadjusted annualized relapse rate (ARR) at Week 96 was 0.145 for BRIUMVI versus 0.496 for teriflunomide, representing a 70.8% relative reduction ...

In this study, researchers aimed to determine whether BCMA-directed CAR T-cell therapy is a feasible first-line option for newly diagnosed multiple myeloma patients who are ineligible for ASCT.

Henry Ford Health has treated the first Michigan patient outside clinical trials with Roctavian, the newly approved gene ...

In the fight against leukemia, even the most advanced treatments carry a significant risk of the disease returning. Now, Chinese scientists have developed a kind of "double-sided tape" that helps the ...

For patients facing cancer treatment, every moment in a hospital can feel daunting. On Friday, Feb. 27, NYC Health + Hospitals/South Brooklyn Health opened ...